Literature DB >> 10900230

Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).

C B Brink1, S M Wade, R R Neubig.   

Abstract

In this study, we investigated the hypothesis of agonist-directed trafficking of receptor signaling for the alpha(2A)-adrenergic receptor (alpha(2A)-AR). alpha(2A)-ARs couple to both G(s) and G(i) to stimulate or inhibit adenylyl cyclase activity. Chinese hamster ovary-K1 cell lines expressing the porcine alpha(2A)-AR at high (alpha(2A)-H) and low (alpha(2A)-L) levels were used to estimate the relative efficacies (R.e.s) of a series of agonists for the G(s) and G(i) pathways. G(s)-mediated responses were measured after pertussis toxin treatment to inactivate G(i) in alpha(2A)-H, whereas G(i) responses were measured in alpha(2A)-L, where G(s) responses were absent. The full agonist UK-14,304 showed a large receptor reserve for G(i) responses in alpha(2A)-H but little receptor reserve for G(s) responses in alpha(2A)-H or for G(i) responses in alpha(2A)-L. With the exception of l-isoproterenol (ISO), all agonists showed similar R.e.s at the alpha(2A)-AR for G(s) and G(i) responses, with rank orders of R.e.s as follows: l-epinephrine = l-norepinephrine = UK-14,304 > p-aminoclonidine > or = BHT-920 > or = BHT-933 > clonidine = p-iodoclonidine > or = xylazine > or = guanabenz. Interestingly, ISO had the highest efficacy at the alpha(2A)-AR for activating G(s) versus G(i) (9-fold higher); however, it had low potency for both. By several criteria, the ISO response was mediated by the alpha(2A)-AR, supporting the hypothesis of agonist-directed trafficking of receptor signaling or agonist-specific G protein selectivity. In contrast, the apparent G(i) pathway selectivity of oxymetazoline appears to be mediated by an endogenous serotonergic receptor. It is intriguing that a classic beta-AR agonist that activates G(s) through beta(2)-ARs also appears to produce a G(s)-selective conformation of the G(i)-coupled alpha(2A)-AR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900230

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Authors:  Steven J Charlton; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 2.  Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.

Authors:  C B Brink; B H Harvey; J Bodenstein; D P Venter; D W Oliver
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

3.  An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.

Authors:  Rajendra Mistry; Mark R Dowling; R A John Challiss
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 4.  Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.

Authors:  Liyun Wang; Bronwen Martin; Randall Brenneman; Louis M Luttrell; Stuart Maudsley
Journal:  J Pharmacol Exp Ther       Date:  2009-08-10       Impact factor: 4.030

5.  Agonist trafficking of G(i/o)-mediated alpha(2A)-adrenoceptor responses in HEL 92.1.7 cells.

Authors:  J P Kukkonen; C C Jansson; K E Akerman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.

Authors:  K A Berg; J D Cropper; C M Niswender; E Sanders-Bush; R B Emeson; W P Clarke
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 7.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

8.  Allosteric potentiators of metabotropic glutamate receptor subtype 1a differentially modulate independent signaling pathways in baby hamster kidney cells.

Authors:  Douglas J Sheffler; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2008-07-02       Impact factor: 5.250

9.  Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.

Authors:  Alison C MacKinnon; Uzma Tufail-Hanif; Mark Wheatley; Adriano G Rossi; Christopher Haslett; Michael Seckl; Tariq Sethi
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 10.  Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad.

Authors:  Joe B Blumer; Stephen M Lanier
Journal:  Mol Pharmacol       Date:  2013-12-03       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.